Tuesday, December 4, 2018

Alembic Pharma#39;s subsidiary gets USFDA nod peptic ulcer drug

Alembic Pharma#39;s subsidiary gets USFDA nod peptic ulcer drug The company#39;s wholly owned subsidiary Orit Laboratories LLC has received approval from the US Food Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Glycopyrrolate tablets USP in the strengths of 1 mg and 2mg, Alembic Pharmaceuticals said in a BSE filing.

from Moneycontrol Business News https://ift.tt/2Qgj9ks
at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally

A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...